Author

Xiaoyan Wang

Children's Hospital of Capital Institute of PediatricsORCID 0000-0002-0800-5864Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xiaoyan Wang2 papers · Adelaide University

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Allan Micheil InnesiD· 1 shared Ana S.A. CoheniD· 1 shared Benjamin CognéiD· 1 shared Bernt PoppiD· 1 shared Bonnie R. SullivaniD· 1 shared Boris KereniD· 1 shared Carrie A. Lahner· 1 shared Chang‐Mei LiuiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Allan Micheil InnesORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MARK2 variants cause autism spectrum disorder via the downregulation of WNT/β-catenin signaling pathway

Maolei Gong, Jiayi Li, Yijun Liu, Matheus Vernet Machado Bressan Wilke, Qian Li, Haoran Liu, Liang Chen, Joel A. Morales‐Rosado, Ana S.A. Cohen, Susan Starling Hughes, Bonnie R. Sullivan, Valerie Waddell, Marie‐José H. van den Boogaard, Richard H. van Jaarsveld, Ellen van Binsbergen, , Xiaoli Chen

This study identifies MARK2 variants as a cause of autism spectrum disorder by showing they disrupt the WNT/β-catenin signaling pathway and impair neural development.

medRxiv · Apr 24, 2024 · PreprintGenetic & Genomic Medicine